| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |